Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · IEX Real-Time Price · USD
15.01
+0.03 (0.20%)
Jul 22, 2024, 9:30 AM EDT - Market open

DAWN Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020
Market Capitalization
1,3091,2711,5831,044-
Market Cap Growth
46.73%-19.71%51.68%--
Enterprise Value
9919051,241759-43
PE Ratio
--6.73-11.13-6.11-
PB Ratio
4.413.674.773.71-
P/FCF Ratio
-8.45-8.64-14.40-21.50-
P/OCF Ratio
-8.46-8.65-14.41-21.50-
EV/EBITDA Ratio
-5.40-4.80-8.76-4.461.07
EV/EBIT Ratio
-5.39-4.79-8.73-4.451.07
EV/FCF Ratio
-6.59-6.15-11.30-15.653.19
Debt / Equity Ratio
0.000.000.000.00-0.01
Debt / EBITDA Ratio
0.000.00-0.010.00-0.01
Debt / FCF Ratio
0.000.00-0.010.00-0.03
Quick Ratio
10.6612.4220.6032.8421.91
Current Ratio
10.9312.7220.9433.4322.58
Interest Coverage
-----1349.23
Return on Equity (ROE)
-57.30%-51.70%-42.30%-83.10%124.90%
Return on Assets (ROA)
-53.30%-48.30%-40.50%-63.70%-111.00%
Return on Capital (ROIC)
-76.40%-59.39%-44.14%-25.85%25.62%
Earnings Yield
-15.96%-14.87%-8.98%-16.35%-
FCF Yield
-13.05%-11.57%-6.94%-4.65%-
Buyback Yield / Dilution
-20.43%-21.85%-77.13%-568.42%6.67%
Total Shareholder Return
-20.43%-21.85%-77.13%-568.42%6.67%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).